Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.085 AUD
−7.32 M AUD
11.34 M AUD
145.98 M
About NUCHEV LIMITED
Sector
CEO
Mick Myers
Headquarters
Melbourne
Website
Founded
2013
ISIN
AU0000067001
FIGI
BBG00QZ1S199
Nuchev Ltd. engages in providing nutritional products. It focuses on the development, marketing, and selling of goat milk-based formula and other nutrition products. The company was founded by Ben McFarlane Dingle on April 9, 2013 and is headquartered in Melbourne, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of NUC is 0.115 AUD — it hasn't changed in the past 24 hours. Watch NUCHEV LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange NUCHEV LIMITED stocks are traded under the ticker NUC.
NUC stock has fallen by −4.17% compared to the previous week, the month change is a −4.17% fall, over the last year NUCHEV LIMITED has showed a −39.47% decrease.
We've gathered analysts' opinions on NUCHEV LIMITED future price: according to them, NUC price has a max estimate of 0.16 AUD and a min estimate of 0.16 AUD. Watch NUC chart and read a more detailed NUCHEV LIMITED stock forecast: see what analysts think of NUCHEV LIMITED and suggest that you do with its stocks.
NUC stock is 0.00% volatile and has beta coefficient of 2.72. Track NUCHEV LIMITED stock price on the chart and check out the list of the most volatile stocks — is NUCHEV LIMITED there?
Yes, you can track NUCHEV LIMITED financials in yearly and quarterly reports right on TradingView.
NUCHEV LIMITED is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
NUC earnings for the last half-year are −0.04 AUD per share, whereas the estimation was −0.03 AUD, resulting in a −33.33% surprise. The estimated earnings for the next half-year are −0.01 AUD per share. See more details about NUCHEV LIMITED earnings.
NUCHEV LIMITED revenue for the last half-year amounts to 4.70 M AUD, despite the estimated figure of 6.00 M AUD. In the next half-year revenue is expected to reach 13.70 M AUD.
NUC net income for the last half-year is −3.90 M AUD, while the previous report showed −3.42 M AUD of net income which accounts for −13.88% change. Track more NUCHEV LIMITED financial stats to get the full picture.
No, NUC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NUCHEV LIMITED EBITDA is −7.15 M AUD, and current EBITDA margin is −56.00%. See more stats in NUCHEV LIMITED financial statements.
Like other stocks, NUC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NUCHEV LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NUCHEV LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NUCHEV LIMITED stock shows the sell signal. See more of NUCHEV LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.